OBECABTAGENE AUTOLEUCEL
OBECABTAGENE AUTOLEUCEL is an active ingredient listed in 1 FDA drug label records from 1 manufacturers marketed mainly as cellular therapy products.
About OBECABTAGENE AUTOLEUCEL
OBECABTAGENE AUTOLEUCEL appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from Autolus Inc.. Approved labelling for these products most frequently references: treatment adults, relapsed refractory, b-cell precursor, acute lymphoblastic, usage aucatzyl, directed genetically, modified autologous, cell immunotherapy. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.
Main manufacturers
| Manufacturer | Products | Marketing type |
|---|---|---|
| Autolus Inc. | 1 | CELLULAR THERAPY |
FDA drug products containing OBECABTAGENE AUTOLEUCEL
| Brand name | Manufacturer | Type | Route | Dosage form |
|---|---|---|---|---|
| AUCATZYL | Autolus Inc. | CELLULAR THERAPY |
Frequently asked questions
How many FDA drug products contain OBECABTAGENE AUTOLEUCEL?
1 FDA drug label records list OBECABTAGENE AUTOLEUCEL as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.
Which companies make OBECABTAGENE AUTOLEUCEL products?
The manufacturers with the most OBECABTAGENE AUTOLEUCEL label records are Autolus Inc.. Generic and brand versions may be produced by different companies.
Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.
This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.